annual shareholders equity:
$288.12M-$266.07M(-48.01%)Summary
- As of today (September 16, 2025), SNDX annual stockholders equity is $288.12 million, with the most recent change of -$266.07 million (-48.01%) on December 31, 2024.
- During the last 3 years, SNDX annual shareholders equity has fallen by -$120.24 million (-29.45%).
- SNDX annual shareholders equity is now -48.01% below its all-time high of $554.20 million, reached on December 31, 2023.
Performance
SNDX Shareholders equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly shareholders equity:
$157.42M-$57.63M(-26.80%)Summary
- As of today (September 16, 2025), SNDX quarterly stockholders equity is $157.42 million, with the most recent change of -$57.63 million (-26.80%) on June 30, 2025.
- Over the past year, SNDX quarterly shareholders equity has dropped by -$276.91 million (-63.76%).
- SNDX quarterly shareholders equity is now -71.59% below its all-time high of $554.20 million, reached on December 31, 2023.
Performance
SNDX quarterly shareholders equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Shareholders equity Formula
Shareholders Equity = Total Assets − Total Liabilities
SNDX Shareholders equity Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -48.0% | -63.8% |
3 y3 years | -29.4% | -56.5% |
5 y5 years | +811.8% | +6.6% |
SNDX Shareholders equity Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -48.0% | at low | -71.6% | at low |
5 y | 5-year | -48.0% | +811.8% | -71.6% | +19.3% |
alltime | all time | -48.0% | +1083.8% | -71.6% | +3613.9% |
SNDX Shareholders equity History
Date | Annual | Quarterly |
---|---|---|
Jun 2025 | - | $157.42M(-26.8%) |
Mar 2025 | - | $215.06M(-25.4%) |
Dec 2024 | $288.12M(-48.0%) | $288.12M(-21.4%) |
Sep 2024 | - | $366.43M(-15.6%) |
Jun 2024 | - | $434.34M(-11.7%) |
Mar 2024 | - | $491.89M(-11.2%) |
Dec 2023 | $554.20M(+18.6%) | $554.20M(+54.3%) |
Sep 2023 | - | $359.19M(-10.2%) |
Jun 2023 | - | $400.04M(-8.1%) |
Mar 2023 | - | $435.50M(-6.8%) |
Dec 2022 | $467.45M(+14.5%) | $467.45M(+38.3%) |
Sep 2022 | - | $338.10M(-6.6%) |
Jun 2022 | - | $361.94M(-3.4%) |
Mar 2022 | - | $374.55M(-8.3%) |
Dec 2021 | $408.37M(+61.9%) | $408.37M(+105.2%) |
Sep 2021 | - | $199.00M(-7.3%) |
Jun 2021 | - | $214.56M(-6.0%) |
Mar 2021 | - | $228.21M(-9.5%) |
Dec 2020 | $252.19M(+698.1%) | $252.19M(+91.1%) |
Sep 2020 | - | $131.98M(-10.6%) |
Jun 2020 | - | $147.65M(+175.9%) |
Mar 2020 | - | $53.51M(+69.3%) |
Dec 2019 | $31.60M | $31.60M(-28.3%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2019 | - | $44.04M(-20.3%) |
Jun 2019 | - | $55.27M(-19.5%) |
Mar 2019 | - | $68.63M(+29.4%) |
Dec 2018 | $53.05M(-49.1%) | $53.05M(-17.5%) |
Sep 2018 | - | $64.27M(-8.6%) |
Jun 2018 | - | $70.35M(-19.1%) |
Mar 2018 | - | $86.95M(-16.6%) |
Dec 2017 | $104.32M(+24.0%) | $104.32M(+7.9%) |
Sep 2017 | - | $96.71M(-11.5%) |
Jun 2017 | - | $109.34M(+50.6%) |
Mar 2017 | - | $72.61M(-13.7%) |
Dec 2016 | $84.14M(+26.1%) | $84.14M(-10.3%) |
Sep 2016 | - | $93.83M(-11.7%) |
Jun 2016 | - | $106.24M(-6.7%) |
Mar 2016 | - | $113.85M(-4516.1%) |
Dec 2015 | $66.70M(-1266.9%) | - |
Dec 2014 | -$5.72M(-148.2%) | - |
Sep 2014 | - | -$2.58M(-159.8%) |
Jun 2014 | - | $4.31M(-48.9%) |
Mar 2014 | - | $8.43M(-28.8%) |
Dec 2013 | $11.85M(-140.5%) | $11.85M(-364.5%) |
Sep 2013 | - | -$4.48M |
Dec 2012 | -$29.29M(+53.7%) | - |
Dec 2011 | -$19.05M | - |
FAQ
- What is Syndax Pharmaceuticals, Inc. annual stockholders equity?
- What is the all time high annual shareholders equity for Syndax Pharmaceuticals, Inc.?
- What is Syndax Pharmaceuticals, Inc. annual shareholders equity year-on-year change?
- What is Syndax Pharmaceuticals, Inc. quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Syndax Pharmaceuticals, Inc.?
- What is Syndax Pharmaceuticals, Inc. quarterly shareholders equity year-on-year change?
What is Syndax Pharmaceuticals, Inc. annual stockholders equity?
The current annual shareholders equity of SNDX is $288.12M
What is the all time high annual shareholders equity for Syndax Pharmaceuticals, Inc.?
Syndax Pharmaceuticals, Inc. all-time high annual stockholders equity is $554.20M
What is Syndax Pharmaceuticals, Inc. annual shareholders equity year-on-year change?
Over the past year, SNDX annual stockholders equity has changed by -$266.07M (-48.01%)
What is Syndax Pharmaceuticals, Inc. quarterly stockholders equity?
The current quarterly shareholders equity of SNDX is $157.42M
What is the all time high quarterly shareholders equity for Syndax Pharmaceuticals, Inc.?
Syndax Pharmaceuticals, Inc. all-time high quarterly stockholders equity is $554.20M
What is Syndax Pharmaceuticals, Inc. quarterly shareholders equity year-on-year change?
Over the past year, SNDX quarterly stockholders equity has changed by -$276.91M (-63.76%)